• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Dermatology

Melanoma immunohistochemical analysis useful to determine BRAFV600E mutation status

bys25qthea
January 25, 2015
in Dermatology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The sensitivity and specificity for VE1 immunohistochemical analysis of BRAFV600E mutations in primary and cutaneous malignant melanomas were 96.7% and 94.5%, respectively.

Evidence Rating Level: 2 (Good)

Study Rundown: Cutaneous malignant melanoma (CMM) is a deadly form of skin cancer. One of the common mutations in superficial spreading melanoma, a subtype of CMM, is the BRAFV600E mutation, which is a target for pharmaceutical therapies. Currently, BRAF mutation status is determined via DNA tests. Immunohistochemical assays are an alternative that could identify the BRAFV600E mutation using the mutation specific VE1 antibody. These assays are less expensive, require less tissue, are more efficient, and are thought to be more sensitive. This study tested the use of VE1 immunohistochemical analysis on CMMs of various subtypes to better characterize BRAFV600E expression. Authors found a high sensitivity and specificity using this modality to determine BRAFV600E mutation status. The strength of the study was the large sample size; however, the study may have been limited as the CMM tumor samples were prepared by a variety of pathology labs, which may have caused variability in the results.

Click to read the study in JAMA Dermatology

Relevant Reading: Signaling Networks in Cutaneous Melanoma Metastasis Identified by Complementary DNA Microarrays

In-Depth [retrospective cohort]: One hundred twenty-four primary tumors and 76 associated metastases demonstrated the BRAFV600E mutation, which was confirmed via DNA mutation analysis. VE1 immunohistochemical analysis was subsequently performed for comparison on the same tumors. The samples consisted predominantly of acral lentiginous melanoma and superficial spreading melanoma (42.7% and 36.3%, respectively). Of all tumors, 63 (46.7%) stained positive for VE1 antibody. Most of these had moderate to strong VE1 staining, however 21 of the VE1 positive tumors stained weakly. Generally, the VE1 staining was homogenous. However in 46.7% of the positively staining tumors, the staining intensity was not equal between primary tumors and corresponding metastases, as the latter stained more weakly. Of this group, only 4 had corresponding differences in mutational status based on DNA analysis. In the full sample, there were 12 tumors that had discordant findings when compared to DNA mutation analysis.

More from this author: More from this author: Tech-aided surveillance of patients at high risk for melanoma aids early diagnosis, Indoor tanning linked to high skin cancer risk in US and abroad, Free drug samples may alter prescription habits of dermatologists, Atopic dermatitis may be more persistent than previously understood

RELATED REPORTS

#VisualAbstract: Vitamin D3 supplementation may reduce disease recurrence in patients with stage II melanoma and low Breslow scores

#VisualAbstract: Incidence of melanoma and non-melanoma skin cancers has increased in the USA over the past three decades

Image: PD/CDC

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: Cutaneous malignant melanoma
Previous Post

Increased risk of non-melanoma skin cancer with subsequent keratinocytes carcinoma

Next Post

Wide-ranging health benefits from outdoor adult walking groups

RelatedReports

#VisualAbstract: Vitamin D3 supplementation may reduce disease recurrence in patients with stage II melanoma and low Breslow scores
StudyGraphics

#VisualAbstract: Vitamin D3 supplementation may reduce disease recurrence in patients with stage II melanoma and low Breslow scores

August 4, 2021
#VisualAbstract: Incidence of melanoma and non-melanoma skin cancers has increased in the USA over the past three decades
StudyGraphics

#VisualAbstract: Incidence of melanoma and non-melanoma skin cancers has increased in the USA over the past three decades

May 19, 2021
Next Post
Wide-ranging health benefits from outdoor adult walking groups

Wide-ranging health benefits from outdoor adult walking groups

AAP strongly opposes marijuana use, supports decriminalization

AAP strongly opposes marijuana use, supports decriminalization

Physical activity calorie equivalent menu labeling may promote exercise

Physical activity calorie equivalent menu labeling may promote exercise

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir
  • Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
  • #VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.